Roche's Avastin is the leader in the renal cancer drugs market. Renal cancer, or kidney cancer, is an important market for pharmaceutical companies, with over 73,000 new cancer cases expected in the U.S. alone in 2020. Apart from Avastin, other approved drugs for renal cancer include ...
Roche's Avastin is the leader in the renal cancer drugs market. Renal cancer, or kidney cancer, is an important market for pharmaceutical companies, with over 73,000 new cancer cases expected in the U.S. alone in 2020. Apart from Avastin, other approved drugs for renal cancer include ...
Share this Article
Recommended